C. Girard

发表

Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

V. Prod’homme, A. Mallavialle, M. Deckert, 2022, Cancer research.

Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma

J. Marine, M. Deckert, G. Vassaux, 2021, bioRxiv.

[Melanoma therapeutic escape: the biomechanical track].

M. Deckert, S. Tartare-Deckert, M. Lecacheur, 2020, Medecine sciences : M/S.

Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma

D. Douguet, C. Bertolotto, V. Biou, 2020, Cancers.

Invasive dedifferentiated melanoma cells inhibit JAK1-STAT3-driven actomyosin contractility of human fibroblastic reticular cells of the lymph node

V. Prod’homme, A. Mallavialle, M. Deckert, 2021, bioRxiv.

A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma

J. Marine, V. Prod’homme, A. Mallavialle, 2020, Cancer Research.

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma

D. Gilot, J. Marine, M. Deckert, 2022, EMBO molecular medicine.

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma

V. Prod’homme, A. Mallavialle, M. Deckert, 2021, EMBO molecular medicine.

Targeting DDR1 and DDR2 overcomes matrix-mediated melanoma cell adaptation to BRAF-targeted therapy

V. Prod’homme, A. Mallavialle, M. Deckert, 2019, bioRxiv.

Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway

V. Prod’homme, M. Deckert, S. Tartare-Deckert, 2019, Oncogene.